Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SGMO | AMGN | GILD | CELG | BIIB |
| Company | Sangamo Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5211 | 301.75 | 65.43 | 108.01 | 221.52 |
| High | 0.5600 | 302.91 | 66.14 | 108.59 | 221.98 |
| Low | 0.5100 | 298.51 | 65.16 | 107.27 | 216.08 |
| Last | 0.5399 | 300.30 | 65.46 | 108.24 | 218.92 |
| Change | +0.0134 | +0.82 | -0.08 | +0.11 | -2.50 |
| % Change | +2.55% | +0.27% | -0.12% | +0.10% | -1.13% |
| Volume | 1,659,500 | 2,452,000 | 7,317,900 | 191,230,496 | 1,156,400 |
| 20-Day Average Volume | 1,341,890 | 2,824,195 | 7,605,850 | 16,188,930 | 1,377,415 |
| Previous Close | 0.5265 | 299.48 | 65.54 | 108.13 | 221.42 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5246 | 275.28 | 66.46 | 108.17 | 204.54 |
| 20-Day Raw Stochastic | 69.66% | 63.99% | 20.81% | 63.25% | 89.44% |
| 20-Day Relative Strength | 45.15% | 63.04% | 34.46% | 64.69% | 56.77% |
| Weighted Alpha | -78.94 | +28.12 | -20.14 | +46.30 | -27.18 |
| Today's Opinion | 40% Sell | 40% Buy | 100% Sell | 100% Buy | 56% Sell |
| Previous Opinion | 40% Sell | 24% Buy | 100% Sell | 100% Buy | 56% Sell |
| Last Month's Opinion | 40% Sell | 24% Sell | 100% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 04/30/24 | +9.62% since 04/30/24 | +0.40% since 04/30/24 | -1.97% since 11/13/19 | +1.91% since 04/30/24 |
| Low | 0.5100 on 05/07/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 213.11 on 05/03/24 |
| High | 0.5739 on 05/01/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 222.40 on 05/06/24 |
| 1-Month | |||||
| %Chg | -3.80% since 04/05/24 | +11.24% since 04/05/24 | -5.92% since 04/05/24 | +5.14% since 10/18/19 | +7.38% since 04/05/24 |
| Low | 0.4600 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 0.5942 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 222.40 on 05/06/24 |
| 3-Month | |||||
| %Chg | +11.39% since 02/07/24 | +1.50% since 02/07/24 | -12.04% since 02/07/24 | +13.63% since 08/20/19 | -8.99% since 02/07/24 |
| Low | 0.4600 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 1.4800 on 02/16/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 244.95 on 02/12/24 |
| 6-Month | |||||
| %Chg | +28.55% since 11/07/23 | +10.77% since 11/07/23 | -18.79% since 11/07/23 | +14.14% since 05/20/19 | -10.87% since 11/07/23 |
| Low | 0.2911 on 11/13/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 1.4800 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 109,247 | 160,633,888 | 81,602,352 | 77,035,920 | 32,238,088 |
| Shares Outstanding, K | 207,496 | 536,376 | 1,245,077 | 711,714 | 145,597 |
| Annual Sales | 176,230,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -257,830,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 2,040,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 2,290,500,000 |
| Last Quarter Net Income | -60,300,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | 393,400,000 |
| 60-Month Beta | 1.40 | 0.60 | 0.22 | 1.41 | -0.01 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 03/13/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 16.07 | 10.99 | 14.50 |